HOME >> MEDICINE >> NEWS
Statins, beta-blockers lessen heart attack risk, says Stanford-Kaiser study

For patients with undiagnosed heart disease, taking medications known as statins and beta-blockers may mean the difference between suffering a heart attack as a first symptom versus experiencing mild chest pain.

New research from the Stanford University School of Medicine suggests that these preventive drugs can steer patients away from having a heart attack toward the less serious symptom of mild chest pain that occurs only with exercise (angina) even if they don't stop the build-up of cholesterol in a patient's arteries. The study, to be published in the Feb. 21 issue of the Annals of Internal Medicine, was conducted with investigators at Kaiser Permanente Division of Research in Oakland and the University of California-San Francisco.

"That's the scary thing about heart disease," said senior author Mark Hlatky, MD, professor of health research and policy and of cardiovascular medicine at Stanford. "You can be fine one minute and dead the next. You can put up with a little chest pain every once in a while if you know you're not about to die from it."

Researchers for the study wanted to know how doctors could help reduce a patient's risk of having a heart attack as a first symptom even if medications for high blood pressure or high cholesterol were unsuccessful in stopping the onset of heart disease. Statins are typically prescribed to reduce cholesterol, one of the warning signs for heart disease. Beta-blockers are given to patients with high blood pressure, another warning sign for heart disease.

"While doctors try to prevent coronary disease by treating high blood pressure and high cholesterol, it's not 100 percent effective," Hlatky said. "If there are warning symptoms like angina with exercise, there is enough time to see a doctor and get started on effective treatments that reduce risk. Having a heart attack causes permanent damage, even if it doesn't kill you."

Researchers evaluated 1,400 patients enrolled within Kaiser
'"/>

Contact: Tracie White
tracie.white@stanford.edu
650-723-7628
Stanford University Medical Center
20-Feb-2006


Page: 1 2

Related medicine news :

1. Experimental gene therapy abolishes arthritis pain and lessens joint damage
2. Warm blanket lessens chances of false-positives in cancer scans
3. Antidepressants lessen risk of heart attack, Stanford researcher says
4. Patients favorite music during surgery lessens need for sedative
5. A broader look at cardiac CTA images often finds diseases/disorders beyond the heart
6. Drug for cluster headaches may cause heart problems
7. Reductive stress linked to heart disease
8. Novel candidate biomarker for heart failure also strongly predicts risk of death
9. Many heart attack patients still not getting emergency clot-busting treatment
10. New heart disease risk score will help minimize health inequalities
11. Metabolic syndrome points to heart health

Post Your Comments:
(Date:5/30/2015)... Ill. (PRWEB) May 30, 2015 Twelve ... were recognized by their peers as the 2015 ... by OncLive® at the Chicago Illuminating Company last night. ... of eminent oncologists for landmark achievements in translational research, ... changed the course of cancer treatment. , Honorees were ...
(Date:5/30/2015)... Thousands of aesthetic industry professionals converged ... by the American Society for Aesthetic Plastic Surgery (ASAPS). ... Zeltiq, the parent company of one of the fastest ... blazing growth, the one-of-a-kind device just sold its 2 ... currently in the news for gaining the FDA’s stamp ...
(Date:5/30/2015)... May 30, 2015 On Thursday, ... Dr. Charles Simone and Dr. Evan Alley both ... ‘Meet the Mesothelioma Experts’ series. The interview was ... mesothelioma centers of excellence. Drs. Simone and Alley ... Mary Hesdorffer, with whom they discussed the mesothelioma ...
(Date:5/30/2015)... May 30, 2015 Responding to surging ... travelers who experienced OGAWA products while abroad, OGAWA-engineered massage ... , A leader in the Asian health and ... designer, researcher, developer and manufacturer of health and wellness ... craftsmanship of their products, health enthusiasts in Asia and ...
(Date:5/30/2015)... 30, 2015 Cyclist Barry Haarde ... for the World 2015: Piles of Miles” near ... awareness about hemophilia and encourage individuals to support ... , Save One Life supports nearly 1,200 impoverished ... countries through direct sponsorships, scholarships and micro-enterprise grants. ...
Breaking Medicine News(10 mins):Health News:OncLive’s 2015 Giant of Cancer Care™ Awards Announced 2Health News:OncLive’s 2015 Giant of Cancer Care™ Awards Announced 3Health News:OncLive’s 2015 Giant of Cancer Care™ Awards Announced 4Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/ltwldz/surgicaloperating ... "Surgical/Operating Microscopes Market by Application & End User ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... to reach $806.6 million by 2020 from $402.2 ... from 2015 to 2020. , ,Major factors fueling ...
(Date:5/29/2015)... 2015  Haemonetics Corporation (NYSE: HAE ) announced ... will present at the JMP Securities Life Sciences Conference ... 23 rd , 2015 at 11:30am Eastern time.  ... live via webcast at: http://wsw.com/webcast/jmp27/hae ... is a global healthcare company dedicated to providing innovative ...
(Date:5/29/2015)... 29, 2015  Epic Sciences announced today that the ... metastatic castrate resistant prostate cancer patients, at the ... Clinical Oncology. This application expands the investigational utility ... platform to characterize circulating tumor cell (CTC) ... patients have heterogeneous clonal CTC populations harboring separate ...
Breaking Medicine Technology:Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3
Cached News: